Spermosens AB (publ) (NGM:SPERM)

Market Cap	30.45M +149.5%
Revenue (ttm)	n/a
Net Income	-9.31M
EPS	-0.00
Shares Out	3.17B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,221,144
Average Volume	9,406,974
Open	0.0110
Previous Close	0.0110
Day's Range	0.0098 - 0.0116
52-Week Range	0.0042 - 0.0138
Beta	0.14
RSI	42.80
Earnings Date	May 7, 2026

About Spermosens AB

Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2018
• Employees: 4
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: SPERM